Novo Nordisk https://www.reuters.com/markets/companies/NOVOb.CO” target=”_blank” rel=”noopener”>(NOVOb.CO) aims to convince Europeans governments to pay for its obesity drug Wegovy for the most overweight or those with co-morbidities, its CEO said on Friday, em…
Read More
About The Author
